Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cancer Biology & Therapy|April 29, 2011
Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanismTunde O Akinyeke, LaMonica V StewartExperimental Biology and Medicine (Maywood, N.J.)|March 27, 2004
Vitamin D and prostate cancerLaMonica V Stewart, Nancy L WeigelThe Prostate|January 15, 2005
Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cellsLamonica V Stewart, Nancy L WeigelJournal of Cellular Physiology|March 7, 2016
The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer CellsEmuejevoke Olokpa, Adrienne Bolden, LaMonica V StewartPPAR Research|November 29, 2017
Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the ProstateEmuejevoke Olokpa, Patrice E Moss, LaMonica V StewartJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 30, 2025
The Meharry Cancer Summer Undergraduate Research Program: A Strategy to Increase Undergraduate Exposure to Cancer Health DisparitiesEvangeline Motley-Johnson, Margaret Whalen, LaMonica V StewartExperimental Cell Research|March 10, 2024
The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescenceTunde Smith, Tytianna White, Zhenbang Chen, et al.Experimental Cell Research|October 12, 2010
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cellsPatrice E Moss, Besstina E Lyles, LaMonica V StewartExperimental Cell Research|March 26, 2003
Regulation of trespin expression by modulators of cell growth, differentiation, and apoptosis in prostatic epithelial cellsLaMonica V Stewart, Kyung Song, Andrew Y Hsing, et al.The Journal of Steroid Biochemistry and Molecular Biology|August 4, 2005
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cellsLaMonica V Stewart, Besstina Lyles, Ming-Fong Lin, et al.Pageof 2